Open Access. Powered by Scholars. Published by Universities.®
- Discipline
-
- Medical Education (5)
- Translational Medical Research (5)
- Diseases (3)
- Gastroenterology (3)
- Nephrology (3)
-
- Digestive System Diseases (2)
- Medical Pharmacology (2)
- Medical Sciences (2)
- Behavioral Medicine (1)
- Chemical and Pharmacologic Phenomena (1)
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)
- Hematology (1)
- Hemic and Lymphatic Diseases (1)
- Internal Medicine (1)
- Medical Humanities (1)
- Medical Pathology (1)
- Mental and Social Health (1)
- Neurology (1)
- Oncology (1)
- Other Medical Sciences (1)
- Pediatrics (1)
- Primary Care (1)
- Radiology (1)
- Substance Abuse and Addiction (1)
- Keyword
-
- Hepatorenal syndrome (3)
- Ascites (2)
- Cirrhosis (2)
- Acute kidney injury (1)
- Acute liver failure (1)
-
- Albumin (1)
- Alcoholic cirrhosis (1)
- Anticoagulation (1)
- Beta-Thalassemia (1)
- Creatinine (1)
- Cryptogenic cirrhosis (1)
- Fresh-frozen plasma (1)
- Hepatology (1)
- Hepatorenal cocktail (1)
- INR reversal (1)
- Interventional radiology (1)
- Liver disease (1)
- Liver transplant (1)
- Luspatercept (1)
- Midodrine (1)
- N-acetylcysteine (1)
- Non-acetaminophen-induced (1)
- Octreotide (1)
- PVT (1)
- Pancreatic cancer (1)
- Portal hypertension (1)
- Portal vein thrombosis (1)
- Prothrombin complex concentrates (1)
- Radiology (1)
- Recombinant factor VIIa (1)
Articles 1 - 8 of 8
Full-Text Articles in Hepatology
Renal Replacement Therapy May Be Initiated In Patients With Hepatorenal Syndrome Who Are Not Transplant Candidates, Laura Donohue
Renal Replacement Therapy May Be Initiated In Patients With Hepatorenal Syndrome Who Are Not Transplant Candidates, Laura Donohue
Clinical Research in Practice: The Journal of Team Hippocrates
A clinical decision report using
Allegretti AS, Parada XV, Eneanya ND, et al. Prognosis of Patients with Cirrhosis and AKI Who Initiate RRT. Clin J Am Soc Nephrol. 2018;13(1):16-25. https://doi.org/10.2215/CJN.03610417
for a patient being considered for RRT who was not yet a candidate for liver transplant.
Substance Abuse Relapse Is Not About Willpower But Is The Culmination Of Psychological And Socioeconomic Stress, Paul A. Steffes
Substance Abuse Relapse Is Not About Willpower But Is The Culmination Of Psychological And Socioeconomic Stress, Paul A. Steffes
Clinical Research in Practice: The Journal of Team Hippocrates
The author reflects on the impact of non-judgmental listening on patient care outcomes.
Interventional Treatment With The Transjugular Intrahepatic Portosystemic Shunt (Tips) Procedure May Offer A Preferable Alternative To Systemic Anticoagulation In Patients With Cirrhosis And Portal Vein Thrombosis, Molly N. Pantelic
Clinical Research in Practice: The Journal of Team Hippocrates
A clinical decision report appraising:
Wang Z, Jiang MS, Zhang HL, et al. Is post-tips anticoagulation therapy necessary in patients with cirrhosis and portal vein thrombosis? A randomized controlled trial. Radiology. 2016;279(3):943-951. https://doi.org/10.1148/radiol.2015150369
for a patient with cryptogenic cirrhosis, gastroesophageal varices, pancreatic cancer, and portal vein thrombosis.
Luspatercept Diminishes The Need For Red Blood Cell Replacement In Transfusion-Dependent Β-Thalassemia Patients, Joudeh B. Freij
Luspatercept Diminishes The Need For Red Blood Cell Replacement In Transfusion-Dependent Β-Thalassemia Patients, Joudeh B. Freij
Clinical Research in Practice: The Journal of Team Hippocrates
A clinical decision report appraising:
Cappellini MD, Viprakasit V, Taher AT, et al. A phase 3 trial of luspatercept in patients with transfusion-dependent β-thalassemia. N Engl J Med. 2020;382(13):1219-1231. https://doi.org/10.1056/NEJMoa1910182
for a patient with transfusion-dependent beta-thalassemia.
Prothrombin Complex Concentrates Or Recombinant Factor Viia Are More Effective Than Fresh-Frozen Plasma At Lowering Inr In Patients With Liver Disease, Abel J. Ignatius
Prothrombin Complex Concentrates Or Recombinant Factor Viia Are More Effective Than Fresh-Frozen Plasma At Lowering Inr In Patients With Liver Disease, Abel J. Ignatius
Clinical Research in Practice: The Journal of Team Hippocrates
A critical appraisal and clinical application of Kwon JO, MacLaren R. Comparison of fresh-frozen plasma, four-factor prothrombin complex concentrates, and recombinant factor VIIa to facilitate procedures in critically ill patients with coagulopathy from liver disease: a retrospective cohort study. Pharmacotherapy. 2016;36(10):1047-1054. doi: 10.1002/phar.1827
Combination Octreotide, Midodrine, And Albumin May Improve Survival In Patients With Hepatorenal Syndrome, But The Evidence Is Weak, Jacob Szafranski
Combination Octreotide, Midodrine, And Albumin May Improve Survival In Patients With Hepatorenal Syndrome, But The Evidence Is Weak, Jacob Szafranski
Clinical Research in Practice: The Journal of Team Hippocrates
A critical appraisal and clinical application of Skagen C, Einstein M, Lucey MR, Said A. Combination treatment with octreotide, midodrine, and albumin improves survival in patients with type 1 and type 2 hepatorenal syndrome. J Clin Gastroenterol. 2009 Aug;43(7):680-5. doi: 10.1097/MCG.0b013e318188947c
It Is Reasonable To Treat Patients With Type 1 Hepatorenal Syndrome With Midodrine And Octreotide, William Kane
It Is Reasonable To Treat Patients With Type 1 Hepatorenal Syndrome With Midodrine And Octreotide, William Kane
Clinical Research in Practice: The Journal of Team Hippocrates
A critical appraisal and clinical application of Esrailian E, Pantangco ER, Kyulo NL, Hu KQ, Runyon BA. Octreotide/midodrine therapy significantly improves renal function and 30-day survival in patients with type 1 hepatorenal syndrome. Dig Dis Sci. 2007;52(3):742-748. doi: 10.1007/s10620-006-9312-0
Salvage Therapy For Non-Acetaminophen-Induced Acute Liver Failure Includes N-Acetylcysteine, David Robinson
Salvage Therapy For Non-Acetaminophen-Induced Acute Liver Failure Includes N-Acetylcysteine, David Robinson
Clinical Research in Practice: The Journal of Team Hippocrates
A critical appraisal and clinical application of Lee WM, Hynan LS, Rossaro L, et al. Intravenous N-acetylcysteine improves transplant-free survival in early stage non-acetaminophen acute liver failure. Gastroenterology. 2009;137(3):856-864. doi: 10.1053/j.gastro.2009.06.006